NCT00140803View on ClinicalTrials.gov

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

January 31, 2007

Conditions
Age-Related Macular Degeneration
Interventions
DRUG

Visudyne

DRUG

Kenalog

Trial Locations (2)

10021

Manhattan Eye, Ear & Throat Hospital, New York

V5Z 3N9

Vh/UBC Eye Care Centre, Vancouver

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

QLT Inc.

INDUSTRY

lead

Manhattan Eye, Ear & Throat Hospital

OTHER